Date published: 2025-10-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

mGBP8 Activators

The initial discovery of such activators would likely begin with the development of a biochemical assay designed to measure the GTPase activity of mGBP8. This assay could be based on the protein's ability to hydrolyze GTP to GDP, a reaction that can be monitored using various techniques, such as the release of inorganic phosphate or the use of fluorescently labeled GTP analogs. The high-throughput screening (HTS) of chemical libraries using these assays would aim to identify compounds that increase the GTP hydrolysis rate, signifying enhanced mGBP8 activity. Hits from the HTS would be considered candidate mGBP8 activators and would be subjected to further validation to confirm their specific activity.

Once candidate activators are identified, secondary validation involves a more detailed examination of the interaction between these molecules and mGBP8. Techniques such as isothermal titration calorimetry (ITC) would provide data on the thermodynamics of the binding interaction, while surface plasmon resonance (SPR) would offer insight into the kinetics of the activator binding to mGBP8. These methods would help confirm whether the observed increase in activity is due to a direct effect of the activator on mGBP8. Further studies, including X-ray crystallography or cryo-electron microscopy (cryo-EM), could provide a detailed three-dimensional structure of the mGBP8 in complex with the activator, shedding light on the molecular basis for activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylate cyclase leading to increased cAMP levels, which may enhance mGBP8's GTPase activity through cAMP-dependent protein kinase (PKA) signaling.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

This polyphenol inhibits protein kinases, potentially reducing inhibitory phosphorylation events and thereby enhancing mGBP8's GTPase activity involved in immune response mechanisms.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC), which may enhance mGBP8's antiviral mechanisms by modulating downstream regulatory proteins involved in the innate immune system.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor which might upregulate pathways leading to the activation of mGBP8, potentially enhancing its role in the immune response to intracellular pathogens.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Binds to sphingosine-1-phosphate receptors potentially influencing the actin cytoskeleton and enhancing mGBP8's localization to pathogen-containing vacuoles for immune response.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A calcium ionophore that increases intracellular calcium, which may enhance mGBP8's role in calcium-dependent signaling pathways related to its immune effector functions.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A broad-spectrum protein kinase inhibitor that may enhance mGBP8's activity by selectively modulating kinases involved in its regulation during the immune response.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that can facilitate changes in the actin cytoskeleton, potentially enhancing mGBP8's ability to target pathogens through cytoskeletal dynamics.